NCT04285476View on ClinicalTrials.gov

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

NAActive, not recruitingINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Thyroid Cancer
Interventions
DIAGNOSTIC_TEST

Signature of microRNA for patients with bethesda classification 3, 4 or 5

If the cytology results are Bethesda 3, 4 or 5, then a miRNA analysis will be performed.

Trial Locations (3)

30029

CHU de Nîmes, Nîmes

31000

CHU de Toulouse, Toulouse

34298

Institut régional du Cancer de Montpellier, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER